Collagen Type III
Research News and Information

Sunday, November 08, 2009

Tenascin-C and type I and III collagen expression in total Achilles tendon rupture. An immunohistochemical study.

29 Sep 2009 Tendon tissue degeneration and changes in collagen composition play a role in spontaneous rupture of the human Achilles tendon. Tenascin-C has been shown to be present in the tissue pathology and changes in tissue loading. We made an ... Read more...

Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons.

29 Sep 2009 Tendinitis remains a catastrophic injury among athletes. Mesenchymal stem cells (MSCs) have recently been investigated for use in the treatment of tendinitis. Previous work has demonstrated the value of insulin-like growth factor-I (IGF-I) to ... Read more...

Histological and molecular analysis of the biceps tendon long head post-tenotomy.

29 Sep 2009 Tendinopathy is a vexing clinical problem as its onset and development is often asymptomatic and unrecognized until tendon rupture. While extensively studied in the rotator cuff, Achilles, and patellar tendons, no study to date has examined the ... Read more...

Latest indexed articles for 'Collagen Type III'

These are the very latest articles for this heading:

• Tenascin-C and type I and III collagen expression in total Achilles tendon rupture. An immunohistochemical study. 29 Sep 2009
• Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons. 29 Sep 2009
• Histological and molecular analysis of the biceps tendon long head post-tenotomy. 29 Sep 2009
• Attenuation of portal hypertension by natural taurine in rats with liver cirrhosis. 26 Sep 2009
• Chronic angiotensin-(1-7) administration improves vascular remodeling after angioplasty through the regulation of the TGF-beta/Smad signaling pathway in rabbits. 24 Aug 2009
• Suppression of collagen production in norepinephrine stimulated cardiac fibroblasts culture: differential effect of alpha and beta-adrenoreceptor antagonism. 30 Jul 2009
• Long-term evaluation of collagen and elastin following infrared (1100 to 1800 nm) irradiation. 30 Jul 2009
• A rat excised larynx model of vocal fold scar. 30 Jul 2009
• Thalidomide has a therapeutic effect on interstitial lung fibrosis: evidence from in vitro and in vivo studies. 30 Jul 2009
• Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. 30 Jul 2009
• Bleeding in the heritable connective tissue disorders: mechanisms, diagnosis and treatment. 7 Jul 2009
• Metabolic extract of Fusarium oxysporum induces histopathologic alterations and apoptosis in the skin of Wistar rats. 29 Jun 2009
• Multilayer tendon slices seeded with bone marrow stromal cells: a novel composite for tendon engineering. 29 Jun 2009
• Effects of pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 in radiation-induced intestinal injury. 29 Jun 2009
• Spice active principles as the inhibitors of human platelet aggregation and thromboxane biosynthesis. 4 Jun 2009
• Healing of extraction sockets in collagenase-2 (matrix metalloproteinase-8)-deficient mice. 30 May 2009
• Cross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community. 30 May 2009
• Association of gene polymorphisms with chronic kidney disease in high- or low-risk subjects defined by conventional risk factors. 30 May 2009
• Remodeling of murine intrasynovial tendon adhesions following injury: MMP and neotendon gene expression. 30 May 2009
• The linker region of Smad2 mediates TGF-beta-dependent ERK2-induced collagen synthesis. 20 May 2009

See a longer list of these articles.

Technical information about 'Collagen Type III'

Definition: A fibrillar collagen consisting of three identical alpha1(III) chains that is widely distributed in many tissues containing COLLAGEN TYPE I. It is particularly abundant in BLOOD VESSELS and may play a role in tissues with elastic characteristics.

Registry Number: 0

Descriptor UI: D024061

Alternative terms: Collagen Type III; Type III Collagen; Collagen, Type III; Collagen Type III, alpha1 Chain; Collagen alpha1(III); Type III Procollagen; Procollagen Type III;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D05.750.078.280.300.300; D12.776.860.300.250.300.300;

History Note: 2002; use COLLAGEN 1990-2001; for PROCOLLAGEN TYPE III use PROCOLLAGEN 1990-2001

Technical Notes: precursors: coord IM with PROCOLLAGEN (IM)